Pharmacology, Toxicology and Pharmaceutical Science
Gonorrhea
100%
Randomized Controlled Trial
92%
Metronidazole
77%
Ceftriaxone
64%
Gentamicin
59%
Pelvic Inflammatory Disease
55%
HIV
51%
Infection
50%
Lactic Acid
44%
Azithromycin
41%
Neisseria gonorrhoeae
40%
Antibiotic Resistance
38%
Antibiotics
37%
Antimicrobial Resistance
25%
Recurrent Disease
23%
Chlamydiae
22%
Adverse Event
21%
Antibiotic Therapy
21%
Syphilis
21%
Tenofovir
21%
Side Effect
20%
Mycoplasma genitalium
18%
Nucleic Acid
18%
Intramuscular Injection
15%
Tolerability
14%
Medicine and Dentistry
Pelvic Inflammatory Disease
77%
Gonorrhea
76%
Randomized Controlled Trial
63%
Infection
62%
Human Immunodeficiency Virus
62%
Metronidazole
57%
Systematic Review
55%
Bacterial Vaginosis
49%
Health Service
36%
Lactic Acid
34%
Neisseria gonorrhoeae
32%
Nucleic Acid Amplification
31%
Antibiotic Resistance
31%
Arm
28%
Mycoplasma genitalium
27%
Antibiotic Therapy
27%
Chlamydiae
26%
Antiretroviral Therapy
26%
Gentamicin
25%
Cohort Analysis
24%
Ceftriaxone
23%
Diagnosis
21%
Health Promotion
21%
Menopausal Symptom
21%
Antibiotics
21%
Nursing and Health Professions
Human Immunodeficiency Virus
66%
Systematic Review
53%
Sexual Violence
53%
Health Service
47%
Gonorrhea
46%
Hospital
41%
Health Center
29%
Odds Ratio
27%
Infection
24%
Intramuscular Drug Administration
22%
Economic Evaluation
21%
Lactic Acid
21%
Metronidazole
21%
Health Care Personnel
21%
Ceftriaxone
20%
Injection Pain
19%
Antibiotic Resistance
19%
Antimicrobial Resistance
18%
Quality of Life
12%
Confidence Interval
11%
Injection Site
11%
Injection Site Pain
11%
Meta Analysis
10%
Efavirenz
10%
Emtricitabine
10%
